Pathophysiology and management of alzheimer’s disease: an overview
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the sixth-leading reason of fatality and is 70% present in all cases of dementia.The global burden of AD is expected to accelerate from 26.6 million cases in 2006 to 106.8 million by 2050.The total assumed worldwide costs of dementia were US$ 604 billion in 2010, equivalent to 1% of the world's Gross domestic product (GDP).This review is focused on the overview of pathophysiology and management of AD.The sources for the literature search were PubMed, ScienceDirect, Scopus and Google Scholar.AD is generally considered as disorders related to intensify loss of neurons and synapses proceeds in distinct anatomical loci, resulting in different phenotypes.The pathophysiology of Alzheimer's disease is credited to a number of factors such as the cholinergic dysfunction, amyloid/tau toxicity and oxidative stress/ mitochondrial dysfunction.Apart from various therapeutic targets, biomarkers and pharmaco-therapies available; Herbal drugs, secondary metabolites and to the some extent non-pharmacological therapies are impending and potential candidates for the management of AD.Further studies are required to elaborate the detailed mechanism of Herbal drugs, secondary metabolites and non-pharmacological therapies for the management of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Alzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217
Antioxidant potential of ferulic acid
Graf, E. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90184-i · Cited by 1,115
Nonpharmacological therapies in Alzheimer’s disease: a systematic review of efficacy
Olazarán, J., Reisberg, B., Clare, L., Cruz, I., Peña-Casanova, J., del Ser, T., Woods, B., Beck, C., Auer, S., Lai, C., et al. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000316119 · Cited by 937
Burns, A., & Iliffe, S. (2009) · BMJ · doi:10.1136/bmj.b158 · Cited by 859
Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., Rock, C. L., Pruitt, M. A., Yang, F., Hudspeth, B., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137455 · Cited by 604
Cited by
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Twarowski, B., & Herbet, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076518 · Cited by 412
Role of natural products for the treatment of Alzheimer’s disease
Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141
Nazir, N., Nisar, M., Zahoor, M., Uddin, F., Ullah, S., Ullah, R., Ansari, S. A., Mahmood, H. M., Bari, A., & Alobaid, A. (2021) · Brain Sciences · doi:10.3390/brainsci11020259 · Cited by 30
“AD is a chronic neurodegenerative disease where the deposition of neuronal amyloid along with a deficit of neurotransmitters; acetylcholine (ACh) level occurs, leading to memory dysfunction [2].”
BackgroundTripathi, S., Kumari, U., & Mitra Mazumder, P. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13504 · Cited by 19
Metadata
- Authors
- Kumar Thakur, A., Kamboj, P., Goswami, K., & Ahuja, K.
- Venue
- Journal of Analytical & Pharmaceutical Research
- Publisher
- MedCrave Group, LLC
- Published
- 2018-04-26
- Volume
- 7
- Issue
- 2
- ISSN
- 2473-0831 (ISSN-L)
- OpenAlex
- W2896669678
- Cited by
- 137
- References
- 18
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiology and management of alzheimer’s disease: an overview. https://app.cochat.ai/papers/10.15406/japlr.2018.07.00230
- The paper
- Kumar Thakur, A., Kamboj, P., Goswami, K., & Ahuja, K. (2018). Pathophysiology and management of alzheimer’s disease: an overview. Journal of Analytical & Pharmaceutical Research. https://doi.org/10.15406/japlr.2018.07.00230
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.